Clinical Trials Sponsored by Second Genome
Total 4487 results
-
Second GenomeTerminatedNonalcoholic SteatohepatitisUnited States
-
Genome & CompanyNot yet recruitingAdvanced Solid TumorsKorea, Republic of
-
Human Genome Sciences Inc.CompletedNon Small Cell Lung CancerUnited States, Germany, Hungary, Romania
-
Human Genome Sciences Inc.CompletedLupus Erythematosus, SystemicUnited States, Canada
-
Human Genome Sciences Inc.CompletedHIV InfectionsUnited States
-
Human Genome Sciences Inc.CompletedSystemic Lupus ErythematosusUnited States
-
Human Genome Sciences Inc.CompletedHepatitis C, ChronicCanada, Australia, Israel, Germany, Czech Republic, France, Poland, Romania
-
Human Genome Sciences Inc.CompletedMultiple MyelomaUnited States, Canada, Australia, India
-
Human Genome Sciences Inc.TerminatedRheumatoid ArthritisUnited States, Poland
-
Human Genome Sciences Inc.CompletedCarcinoma, Non-Small-Cell LungUnited States
-
Human Genome Sciences Inc.CompletedLymphoma, Non-HodgkinUnited States
-
Human Genome Sciences Inc.Completed
-
Human Genome Sciences Inc.Withdrawn
-
Human Genome Sciences Inc.CompletedAdvanced Solid TumorsUnited States
-
Human Genome Sciences Inc.CompletedArthritis, RheumatoidUnited States
-
Human Genome Sciences Inc.Completed
-
Human Genome Sciences Inc.TerminatedLymphoid MalignanciesUnited States, United Kingdom
-
Eurofins GenomaEnrolling by invitationEndometriosis | HypofertilityItaly
-
Human Genome Sciences Inc.GlaxoSmithKlineCompletedSystemic Lupus ErythematosusUnited States, Spain, Israel, Netherlands, Canada, Germany, Poland, Romania, Puerto Rico, Costa Rica, Belgium, Slovakia, United Kingdom, Mexico, Italy, Austria, Czech Republic, Sweden, France
-
Human Genome Sciences Inc.GlaxoSmithKlineCompletedSystemic Lupus ErythematosusHong Kong, Taiwan, Korea, Republic of, India, Chile, Argentina, Philippines, Colombia, Brazil, Romania, Australia, Peru, Russian Federation
-
NovartisHuman Genome Sciences Inc.CompletedChronic Hepatitis CTaiwan, Germany, Greece, Italy, Spain, United Kingdom, France, Canada, Australia, India, Poland, Thailand
-
GlaxoSmithKlineHuman Genome Sciences Inc.Completed
-
Human Genome Sciences Inc.NovartisCompletedChronic Hepatitis CKorea, Republic of, United States, Spain, Canada, France, Australia, Israel, Singapore, Thailand, Malaysia, Sweden, Belgium, Germany, Taiwan, Poland, Argentina, India, Puerto Rico, Brazil, Mexico, United Kingdom
-
Human Genome Sciences Inc.NovartisCompletedChronic Hepatitis CUnited States, Spain, Canada, France, Australia, Italy, Israel, Poland, United Kingdom, Germany, Czech Republic, Romania, Austria, India, Puerto Rico
-
Human Genome Sciences Inc.GlaxoSmithKlineTerminatedSystemic Lupus ErythematosusUnited States, Mexico
-
Human Genome Sciences Inc.GlaxoSmithKlineCompleted
-
University of British ColumbiaGenome British Columbia; Genome Canada; Dynacare Laboratories, Inc.RecruitingAdverse Drug Reaction (ADR)Canada
-
CHU de Quebec-Universite LavalLaval University; Genome Canada; Genome Quebec; CERSSPLCompletedShared Decision MakingCanada
-
GlaxoSmithKlineHuman Genome Sciences Inc.CompletedSystemic Lupus ErythematosusKorea, Republic of, Japan
-
GlaxoSmithKlineHuman Genome Sciences Inc.CompletedSystemic Lupus ErythematosusKorea, Republic of, China, Japan
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR); Laval University; Genome British... and other collaboratorsCompletedTrisomy 21 | Trisomy 18 | Trisomy 13Canada
-
Genome & CompanyMerck Sharp & Dohme LLCRecruitingBiliary Tract CancerKorea, Republic of
-
PrenomeRecruitingPregnancy Complications | Pregnancy Related | Gestational Diabetes | Risk Reduction | Genetic PredispositionUnited States
-
Genome & CompanyMerck KGaA, Darmstadt, GermanyActive, not recruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of
-
SensomeNot yet recruiting
-
SensomeRecruitingPeripheral Vascular DiseaseBelgium
-
SensomeRecruitingStrokeAustralia, France
-
SanomeWithdrawnAsthma | COPD | Dyspnea | Shortness of Breath | Asthma Chronic | Wheezing | Breathlessness
-
Andrew PennHeart and Stroke Foundation of Canada; Genome British Columbia; Bruker Daltonics and other collaboratorsCompleted
-
Ottawa Heart Institute Research CorporationGenome CanadaRecruiting
-
University of PennsylvaniaHuman Genome Sciences Inc.TerminatedDesensitizationUnited States
-
Shaoxing Second HospitalUnknown
-
Genome & CompanyPfizer; Merck KGaA, Darmstadt, GermanyCompletedSolid Tumor | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Urothelial CarcinomaUnited States
-
Jewish General HospitalExactis Innovation; Genome QuebecCompletedTriple Negative Breast CancerCanada, United States
-
Human Genome Sciences Inc.GlaxoSmithKline; Emergent BioSolutionsCompletedTherapeutic Treatment of Inhalation Anthrax
-
Human Genome Sciences Inc.GlaxoSmithKline; Emergent BioSolutionsCompleted
-
Novartis PharmaceuticalsHuman Genome Sciences Inc.TerminatedChronic Hepatitis BTaiwan, Poland, China, Hong Kong, Thailand
-
Cancer Trials AustraliaHuman Genome Sciences Inc.UnknownSymptomatic Waldenstroms MacroglobulinaemiaAustralia
-
National Human Genome Research Institute (NHGRI)Sio Gene TherapiesRecruitingGangliosidosis | Lysosomal Diseases | GM1United States